NHIA releases state of home infusion report
By HME News Staff
Updated 8:29 AM CDT, Thu March 12, 2026
.jpg)
ALEXANDRIA, Va. – The National Home Infusion Association (NHIA) has released its latest report on the home and alternate site infusion industry’s market position based on claims data from a three-year timeframe. Infusion Industry Trends shows the industry’s evolution across therapy categories and payer environments, as well as provides insight into emerging market dynamics, operations pressures and strategic opportunities, the NHIA says. “Home and alternate site infusion continues to demonstrate resilience and adaptability amid the evolving demands of care delivery,” said NHIA CEO and President Connie Sullivan. “With a growing pipeline of complex infused therapies and continued emphasis on value, home infusion is playing a more central role in improving access, quality and system efficiency. At the same time, the report findings underscore meaningful opportunities to better align policy with the realities of modern infusion care – particularly with Medicare.” The report groups therapies offered by providers into five categories: anti-infectives, home enteral nutrition, parenteral nutrition, specialty infusion, and immune globulin. It also uses data to draw out the differences in reimbursement between commercial payers and Medicare, and highlights the areas in which Medicare coverage is fragmented and incomplete. The report is available for free to NHIA members and can be purchased by non-members at nhia.org/trends.
Comments